期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱![]() | Current Drug Delivery LetPub Score 5.4
50 ratings
Rate
Reputation 6.4 Influence 3.9 Speed 9.2 | ||||||||||||||||
期刊簡稱 | CURR DRUG DELIV | ||||||||||||||||
ISSN | 1567-2018 | ||||||||||||||||
E-ISSN | 1875-5704 | ||||||||||||||||
h-index | 54 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 7.10%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://benthamscience.com/journal/index.php?journalID=cdd | ||||||||||||||||
在線稿件提交 | http://bsp-cms.eurekaselect.com/index.php/CDD/login?source=%2Findex.php%2FCDD | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Bentham Science Publishers B.V. | ||||||||||||||||
主題領域 | PHARMACOLOGY & PHARMACY | ||||||||||||||||
出版國/地區 | U ARAB EMIRATES | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 0 | ||||||||||||||||
每年文章數 | 139每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 0.57% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1567-2018%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[Current Drug Delivery] 的評論 | 撰寫評論 |
作者: LinTong 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2025-03-27 09:40:42 評論於 The article submitted on 3.19 is still awaiting editor approval today. ![]() ![]() |
作者: 是你的以秋呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-05 13:02:41 評論於 The article processing fee is 490 US dollars. ![]() ![]() |
作者: 六合嘉赫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-08 22:11:34 評論於 May I ask if there is a layout fee to be charged? ![]() ![]() |
作者: 半π 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-23 09:49:05 評論於 I don't know if it will rise against the trend by 0.4% this year or rise to 4% next year. ![]() ![]() |
作者: 等等等等等邓呐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-05-07 11:28:50 評論於 When did you become so different? ![]() ![]() |
作者: 努力啊大慕玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-26 16:31:22 評論於 Review speed: 2.0 | Submission success rate: 50.0 Feedback: The editors are nice and the external review is quite fast. I received feedback in one month. Hope everything goes smoothly ![]() ![]() |
作者: 万花飞槐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-23 23:20:00 評論於 very slow ![]() ![]() |
作者: 无妄雅柔 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-27 08:55:05 評論於 Is this magazine quick to publish after accepting submissions? ![]() ![]() |
作者: 努力啊大慕玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-19 08:01:49 評論於 Review Speed: 1.0 | Submission Hit Rate: 50.0 Emphasized Research Direction: Drug Delivery Systems Experience Sharing: It has been almost half a month and still awaiting editor approval ![]() ![]() |
作者: 问儿酱吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-08 22:55:51 評論於 Could you tell me how long the approximate turnaround time is for submitting an article to Current Drug Delivery? I have been in the "awaiting for initial checking" status for a long time and it feels very slow ![]() ![]() |
作者: Alva Penn 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-06 18:04:59 評論於 Do you need a layout fee of $490? ![]() ![]() |
作者: 北海秀慧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-29 09:45:14 評論於 Please translate the following paragraph into English and Japanese ![]() ![]() |
作者: 孤云崇学 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-11 23:04:18 評論於 Hello, may I help you? ![]() ![]() |
作者: 孤云崇学 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-11 12:05:52 評論於 Hello, may I help you? ![]() ![]() |
作者: 雨巷少年嘉歆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-09 21:08:10 評論於 Does it take half a month from submission to Awaiting For Initial Checking? Is it particularly slow? ![]() ![]() |
作者: 雨巷少年嘉歆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-02-08 08:58:30 評論於 Is this magazine very slow? It has been half a month and it just started awaiting for initial checking. Is there any hope? ![]() ![]() |
作者: 一只己未呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-11 19:32:00 評論於 May I ask for the English and s of the following paragraph? ![]() ![]() |
作者: 岭南和玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-03 10:02:29 評論於 Hello, are you online now? My article has been pre-accepted for over two months. Yesterday I received a request for image quality optimization and I paid over 100 dollars. How long will it take for my article to be online? ![]() ![]() |
作者: 北海秀慧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-31 17:29:17 評論於 Do you need a $490 processing fee for the article? ![]() ![]() |
作者: 北海秀慧 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-31 08:06:29 評論於 It seems like we might need to consider choosing an OA (online application) as well ![]() ![]() |
作者: 岭南和玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-07-21 16:33:45 評論於 Review Speed: 2.0 Experience Sharing: Submitted in early March, received major revisions in early May, accepted one week after revisions, but now it's almost the end of July... and still no proof... Difficulty is not high, those with more time on their hands can give it a try. Also, the impact factor has increased a lot this year, from 2.5 to 3.8 ![]() ![]() |
作者: 岭南和玉 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-05-09 08:39:29 評論於 If you don't choose OA, you won't need it anymore ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:23:35 評論於 The corresponding author of a SCI journal article does not necessarily have to be only one person, there is no fixed standard for the specific number of authors. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only accept one corresponding author, if the paper has multiple corresponding authors, the first corresponding author will automatically be selected as the corresponding author. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same applies to other requirements. In other words, the number of authors listed as corresponding authors must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiments and writing of the article, and is the person who is listed first in the author list. However, in collaborative work, it is common to have multiple co-first authors. There is no specific rule regarding the number of co-first authors, and it depends largely on the workload of the paper, its length, the regulations of the publishing journal, and the recognition of the institution. Generally, it is most common for a SCI paper to have 2-4 co-first authors ![]() ![]() |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 13:28:25 評論於 Less commonly, it is usually the full Chinese name spelled out ![]() ![]() |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 21:43:48 評論於 How many corresponding authors can there be at most? How many first authors can there be at most? ![]() ![]() |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us